Yongzeng Wang
Overview
Explore the profile of Yongzeng Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
3037
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Borquez-Ojeda O, Stefanski J, Du F, Qu J, Chaudhari J, et al.
Mol Ther Methods Clin Dev
. 2021 Sep;
22:377-387.
PMID: 34514029
With the US Food and Drug Administration (FDA) approval of four CD19- and one BCMA-targeted chimeric antigen receptor (CAR) therapy for B cell malignancies, CAR T cell therapy has finally...
2.
Piao J, Zabierowski S, Dubose B, Hill E, Navare M, Claros N, et al.
Cell Stem Cell
. 2021 Feb;
28(2):217-229.e7.
PMID: 33545080
Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra leading to disabling deficits. Dopamine neuron grafts may provide a significant therapeutic advance over current therapies....
3.
Sauter C, Senechal B, Riviere I, Ni A, Bernal Y, Wang X, et al.
Blood
. 2019 Jul;
134(7):626-635.
PMID: 31262783
High-dose chemotherapy and autologous stem cell transplantation (HDT-ASCT) is the standard of care for relapsed or primary refractory (rel/ref) chemorefractory diffuse large B-cell lymphoma. Only 50% of patients are cured...
4.
Geyer M, Riviere I, Senechal B, Wang X, Wang Y, Purdon T, et al.
JCI Insight
. 2019 Apr;
5.
PMID: 30938714
Background: Subgroups of patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) exhibit suboptimal outcomes after standard therapies, including oral kinase inhibitors. We and others have previously reported on...
5.
Geyer M, Riviere I, Senechal B, Wang X, Wang Y, Purdon T, et al.
Mol Ther
. 2018 Jun;
26(8):1896-1905.
PMID: 29910179
Patients with residual chronic lymphocytic leukemia (CLL) following initial purine analog-based chemoimmunotherapy exhibit a shorter duration of response and may benefit from novel therapeutic strategies. We and others have previously...
6.
Park J, Riviere I, Gonen M, Wang X, Senechal B, Curran K, et al.
N Engl J Med
. 2018 Feb;
378(5):449-459.
PMID: 29385376
Background: CD19-specific chimeric antigen receptor (CAR) T cells induce high rates of initial response among patients with relapsed B-cell acute lymphoblastic leukemia (ALL) and long-term remissions in a subgroup of...
7.
Geyer M, Manjunath S, Evans A, Park J, Davila M, Cutler C, et al.
Leuk Lymphoma
. 2017 Oct;
59(7):1717-1721.
PMID: 29043880
No abstract available.
8.
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
Davila M, Riviere I, Wang X, Bartido S, Park J, Curran K, et al.
Sci Transl Med
. 2014 Feb;
6(224):224ra25.
PMID: 24553386
We report on 16 patients with relapsed or refractory B cell acute lymphoblastic leukemia (B-ALL) that we treated with autologous T cells expressing the 19-28z chimeric antigen receptor (CAR) specific...
9.
Wang Y, Gaba V, Yang J, Palukaitis P, Gal-On A
Phytopathology
. 2008 Oct;
92(1):51-8.
PMID: 18944139
ABSTRACT Mixed infections of cucurbits by Cucumber mosaic virus (CMV) and potyviruses exhibit a synergistic interaction. Zucchini squash and melon plants coinfected by the potyvirus Zucchini yellow mosaic virus (ZYMV)...
10.
Moreau M, Lee G, Wang Y, Crane B, Klessig D
J Biol Chem
. 2008 Sep;
283(47):32957-67.
PMID: 18801746
AtNOS1 was previously identified as a potential nitric-oxide synthase (NOS) in Arabidopsis thaliana, despite lack of sequence similarity to animal NOSs. Although the dwarf and yellowish leaf phenotype of Atnos1...